Michael Burgess actually said...

This should have been an ongoing exercise over the last decade, in my opinion.

I also want to take a minute to applaud my friend from Oregon, Rep. Schrader, and Rep. Bilirakis, for working together on pursuing additiona...

It is important. I am glad we are able to come together in a bipartisan fashion to make this happen.

Reauthorizing improved generic and biosimilar user fee programs will lead to timelier approvals and lower drug costs. It's that simple.